Novavax Inc financial data

Symbol
NVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Quince Orchard Road, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 87.4 % +35.4%
Quick Ratio 1.58 % -28.6%
Debt-to-equity -363 % -6.37%
Return On Equity 44.8 % -39.5%
Return On Assets -17.1 % +44.5%
Operating Margin -34.1 % +43%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 160M shares +34.8%
Common Stock, Shares, Outstanding 160M shares +34.9%
Entity Public Float 699M USD -82.6%
Common Stock, Value, Issued 1.62M USD +35.1%
Weighted Average Number of Shares Outstanding, Basic 160M shares +54.7%
Weighted Average Number of Shares Outstanding, Diluted 160M shares +54.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 885M USD -15.7%
Cost of Revenue 321M USD -13.4%
Research and Development Expense 451M USD -45.6%
General and Administrative Expense 414M USD -12.9%
Costs and Expenses 1.19B USD -29.2%
Operating Income (Loss) -301M USD +51.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -280M USD +49.2%
Income Tax Expense (Benefit) 5.12M USD -48.1%
Net Income (Loss) Attributable to Parent -285M USD +48.1%
Earnings Per Share, Basic -2.11 USD/shares +67.1%
Earnings Per Share, Diluted -2.14 USD/shares +66.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 574M USD -11.9%
Marketable Securities, Current 336M USD
Inventory, Net 8.64M USD -87.6%
Other Assets, Current 156M USD +104%
Assets, Current 1.1B USD +9.63%
Property, Plant and Equipment, Net 286M USD -5.07%
Operating Lease, Right-of-Use Asset 25M USD -31.3%
Intangible Assets, Net (Excluding Goodwill) 8.46M USD +68.2%
Goodwill 127M USD +2.41%
Other Assets, Noncurrent 30.5M USD -12.4%
Assets 1.71B USD +3.34%
Accounts Payable, Current 57.5M USD -43.6%
Employee-related Liabilities, Current 56M USD +6.44%
Accrued Liabilities, Current 219M USD -29.7%
Contract with Customer, Liability, Current 613M USD +219%
Liabilities, Current 1.18B USD -19.6%
Contract with Customer, Liability, Noncurrent 515M USD -15.4%
Operating Lease, Liability, Noncurrent 28.6M USD -42.9%
Other Liabilities, Noncurrent 319M USD +755%
Liabilities 2.24B USD -4.14%
Accumulated Other Comprehensive Income (Loss), Net of Tax 3.6M USD
Retained Earnings (Accumulated Deficit) -4.93B USD -6.14%
Stockholders' Equity Attributable to Parent -526M USD +22.4%
Liabilities and Equity 1.71B USD +3.34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -83.6M USD +74.3%
Net Cash Provided by (Used in) Financing Activities 5.89M USD
Net Cash Provided by (Used in) Investing Activities -7.25M USD +69.2%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 162M shares +35%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -87.9M USD +87.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 589M USD -11.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.21M USD -81.6%
Deferred Tax Assets, Valuation Allowance 1.13B USD +10.7%
Deferred Tax Assets, Gross 1.19B USD +12.3%
Operating Lease, Liability 113M USD -10.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -269M USD +49.8%
Lessee, Operating Lease, Liability, to be Paid 161M USD +7.44%
Property, Plant and Equipment, Gross 381M USD +11.5%
Operating Lease, Liability, Current 23M USD +36.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.2M USD -30.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 34.4M USD -27.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 48.2M USD +98.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.6M USD +30.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 4.24M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14M USD +33.2%
Additional Paid in Capital 4.49B USD +10.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 57.9M USD +57.7%
Share-based Payment Arrangement, Expense 53.4M USD -45.3%
Interest Expense 14.2M USD -26.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%